NGMDF (NuGen Medical Devices) Additional Paid-In Capital: $0.00 Mil(As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is NuGen Medical Devices Additional Paid-In Capital?

NuGen Medical Devices NGMDF Additional Paid-In Capital is $0.00 Mil as of Jun. 2026. The stock has 7 warning signs investors should review.


NuGen Medical Devices Additional Paid-In Capital Related Terms

NuGen Medical Devices Additional Paid-In Capital Historical Data

* Premium members only.

The historical data trend for NuGen Medical Devices's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NuGen Medical Devices Additional Paid-In Capital Chart

NuGen Medical Devices Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Additional Paid-In Capital
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

NuGen Medical Devices Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NuGen Medical Devices Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)
What does a Additional Paid-In Capital of $0.00 Mil mean?
NuGen Medical Devices (NGMDF) has a Additional Paid-In Capital of $0.00 Mil as of Jun. 2026. Additional paid-in capital is the capital a company raises in excess of par value. View historical data on NuGen Medical Devices and its competitors.
Is NuGen Medical Devices' Additional Paid-In Capital too high?
NuGen Medical Devices' current Additional Paid-In Capital is $0.00 Mil.
How does NuGen Medical Devices' Additional Paid-In Capital compare to ABT and SYK?
NuGen Medical Devices' Additional Paid-In Capital of $0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Additional Paid-In Capital for a Medical Devices & Instruments company?
A good Additional Paid-In Capital depends on the Medical Devices & Instruments industry context. However, Additional Paid-In Capital should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Additional Paid-In Capital mean?
A high Additional Paid-In Capital can signal that a stock is expensive relative to its fundamentals. Additional paid-in capital is the capital a company raises in excess of par value. View historical data on NuGen Medical Devices and its competitors. NuGen Medical Devices's current Additional Paid-In Capital is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NuGen Medical Devices stock overvalued right now?
Based on GuruFocus' analysis, NuGen Medical Devices (NGMDF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.02, compared to a current price of $0.01 — trading 52.5% below its estimated fair value. The current Additional Paid-In Capital is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Additional Paid-In Capital calculated?
Additional Paid-In Capital is calculated from a company's financial statements. For NuGen Medical Devices (NGMDF), the current Additional Paid-In Capital is $0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NuGen Medical Devices Business Description

Other Exchanges 79O:GermanyNGMD:Canada
Address 18 King Street East, Suite 1400, Toronto, ON, CAN, M5C 1C4
NuGen Medical Devices Inc is a medical device manufacturing company specializing in the field of needleless injections and related technologies. The reportable segment of the company is the manufacturing of needle injector devices. Geographically, the company generates revenue from Europe, followed by Asia, and other.